• InterView
• Approval called for drug switching in atopic dermatitis
• by Whang, byung-woo Jan 24, 2025 05:51am

• InterView
• "Reimb granted to drug switching between JAK inhibitors"
• by Son, Hyung Min Dec 26, 2024 05:50am

• InterView
• ‘New start at a law firm…will become a trusted expert’
• by Kim, Jin-Gu Dec 13, 2024 05:52am

• InterView
• ‘3 IBD treatment trends…early treatment is the first’
• by Kim, Jin-Gu Dec 2, 2024 05:49am

• InterView
• ‘Improve new drug access to treat rheumatoid arthritis'
• by Son, Hyung Min Nov 21, 2024 05:46am

• InterView
• 'Early detection of RA can help prevent severe symptoms'
• by Whang, byung-woo Nov 14, 2024 05:51am

• InterView
• "Recruiting a company to co-develop pitavastatin+ezetimibe"
• by Kim, Jin-Gu Oct 30, 2024 05:54am

• InterView
• "JAK inhibitors bring a paradigm shift to RA treatment"
• by Whang, byung-woo Oct 16, 2024 05:50am

• InterView
• "An OTC drug increases lymphedema patient satisfaction"
• by Kim, Jin-Gu Sep 23, 2024 05:50am

• InterView
• ‘Era of once-weekly growth hormones…adherence is key’
• by Hwang, Byung-woo Sep 13, 2024 05:49am